Developer docs
API playgroundTry for free, no card

Search company profiles

AMSilk

Full company profile

uuid00006jr

Namestring
AMSilk
Legal namestring
AMSilk GmbH
Websiteurl
amsilk.com
Company typeenum
Private
Founded yearint
2008
Descriptiontext

AMSilk GmbH is a German industrial biotechnology company founded in 2008 as a spin-off from the Technical University of Munich that produces biofabricated silk proteins through precision fermentation using genetically engineered microorganisms. The company's core platform combines DNA editing with AI-powered protein design to engineer spider-silk-inspired proteins, which are then processed into a portfolio of physical forms including fibers and yarns (Biosteel®), hydrogels (Silkgel), microparticles (Silkbeads), sprayable formulations, and powders (AMSilk4Care, AMSilk4Shine). Products are positioned as biodegradable, vegan-certified, microplastic-free alternatives to conventional silk and synthetic polymers, with claimed performance characteristics including up to 120 kg CO2-equivalent savings per kilogram of fiber and 99.7% reduction in microbial adherence in medical coating applications.

AMSilk serves enterprise customers across five primary business units: textile and fashion (Balenciaga Spring 2026 collection, adidas Futurecraft Biofabric), medical technology (coatings, wound dressings, surgical mesh), consumer care (laundry, dish, surface, and personal care formulators), automotive (Mercedes-Benz VISION EQXX door pulls), and aviation (Airbus composite fibers). The company does not own fermentation plants; instead, it operates an asset-light contract manufacturing model through dedicated lines at Evonik in Slovakia and Ajinomoto Foods Europe in France, with multi-ton monthly output and a publicly stated target of scaling capacity by several thousand tons per year within 3-5 years.

Revenue is generated through a mix of B2B biomaterial sales (fibers, yarns, powders, hydrogels, coatings), licensing and strategic partnership agreements under a three-tier model (Partnership, Preferred Partnership, Strategic Partnership), and consumer care ingredient supply. Cumulative disclosed funding exceeds EUR 106M across a EUR 54M Series C (2021-2023) and a EUR 52M round in September 2025 led by ATHOS (AT Newtec, majority shareholder), with participation from Novo Holdings, Cargill, and MIG Capital. As of June 2026, leadership transitioned to a new CEO (Christian Wichert, ex-Evolva AG) explicitly tasked with moving the company from development and scale-up to full commercialization.

Short descriptiontext

AMSilk GmbH produces biofabricated silk proteins via precision fermentation, supplying fibers, yarns, hydrogels, and powders to enterprise customers in luxury fashion, automotive, aerospace, medical, and consumer care industries through direct B2B sales and contract manufacturing partners Evonik and Ajinomoto.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNeuried, Germany
HQ citystring
Neuried
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biotech silk proteins, biofabricated materials, precision fermentation proteins, sustainable textile fibers, biogenic material solutions
Industry4 codes
PRIMARYIMAOAAAB
Man-Made Fiber Manufacturing (Polyester/Nylon/Acrylic/Viscose)
SECONDARYIMAOABAH
Technical Fabric Mills (Performance/Protective/Medical Substrates)
SECONDARYIMAOADAD
Medical & Hygiene Technical Textiles (Gauze/Drapes/Wipes/Barrier Fabrics)
SECONDARYIMAMALAK
Bio-based Textiles & Fibers (lyocell/viscose, cellulose filament, nonwovens)
NAICS code2 codes
  • Artificial and Synthetic Fibers and Filaments Manufacturing32522
  • Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing3252
SIC code1 code
  • Broadwoven Fabric Mills, Man Made Fiber & Silk2221
Product category
Biofabricated Silk Protein Materials
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Biomaterial Sales
TypeOne Time License
Description

AMSilk generates revenue through the sale of biofabricated silk protein materials including fibers, yarns, powders, hydrogels, and coatings to industrial customers in textiles, medical, consumer care, automotive, and aviation sectors.

amsilk.com
2Licensing and Partnership Agreements
TypeLicensing Royalties
Description

Revenue generated from preferred and strategic partnership agreements with industry leaders, including technology licensing and custom product development collaborations.

amsilk.com
3Consumer Care Ingredients
TypeSubscription Recurring
Description

Sale of silk protein ingredients (AMSilk4Care, AMSilk4Shine) to consumer care product manufacturers for use in laundry care, dish care, personal care, and surface cleaning products.

amsilk.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Biosteel®
Description

High-performance bio-fabricated silk protein fiber brand for textiles and industrial applications

amsilk.com
+2 more records
Core offering1 text field

AMSilk manufactures and sells biofabricated silk protein materials produced through precision fermentation using genetically engineered microorganisms. Its product portfolio includes high-performance silk protein yarns (Biosteel) for textiles, AMSilk4Care and AMSilk4Shine protein ingredients for consumer care products, and medical-grade coatings for implants, with applications spanning luxury fashion, athletic apparel, automotive interiors, aerospace, and medical devices.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Up to 120 kg CO2 equivalent saved per kilogram of AMSilk fiber replacing conventional silk
+2 more records
Product and service3 records
1AMSilk Silk Protein Yarns (Biosteel)
CategoryBiofabricated Textile Fibers
Description

High-performance biofabricated silk protein yarns (Biosteel) produced via precision fermentation and proprietary wet spinning for textile applications including luxury fashion garments, performance footwear, technical textiles, automotive interiors, and aerospace composites. Customers include adidas, Balenciaga, Mercedes-Benz, Airbus, and OMEGA.

2AMSilk4Care
CategoryConsumer Care Ingredients
Description

Pure biotech silk protein formulation for consumer care applications including laundry care, surface cleaning, hair care, and skin care products. Sold as a functional, biodegradable ingredient to consumer care product manufacturers seeking alternatives to synthetic polymers.

3AMSilk4Shine
CategoryConsumer Care Ingredients
Description

Silk shine protein ingredient designed for dish care formulations, delivering surface protection, anti-spotting, and anti-streaking performance in home care products. Sold to consumer care manufacturers as a biodegradable alternative to synthetic polymers.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-01-21
Description

Bioengineered silk protein yarns featured in commercially available garments within Balenciaga's Spring 2026 collection. Significant milestone demonstrating biotech materials meet luxury fashion requirements.

2Ajinomoto Foods Europe
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-10-16
Description

Strategic partnership for industrial fermentation of silk proteins at Ajinomoto's facility in Nesle, France. Leverages Ajinomoto's 50+ years of fermentation expertise, bioreactors exceeding 100m³ scale, and proximity to European customers with renewable energy and local raw materials.

amsilk.com
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2024-03-05
Description

Strategic R&D collaboration for protein engineering. Using rational design and AI-powered technologies to optimize structural proteins at amino acid level for performance materials. Successfully registered first PCT patent for optimized protein.

Strategic tierMajorTypeTechnology or IntegrationAnnounced on2024-01-17
Description

Partnership to accelerate production of advanced materials made from spider silk-based proteins. New protein production strain delivers unprecedented yield with greater efficiency and lower costs.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2023-04-04
Description

Long-term manufacturing partnership with dedicated production line at Evonik's Slovakian site for industrial-scale silk protein production. Evonik provides precision fermentation capabilities with advanced infrastructure and renewable energy, producing several tons of silk proteins monthly.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2022-01-03
Description

Partnership to develop sustainable bio-based door pulls for VISION EQXX concept car. First use of biotechnology-based certified-vegan silk-like fabric in automotive sector, showcasing application potential of AMSilk's technology.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2018-09-12
Description

Partnership to develop next generation composite fibers for lightweight, high-performance planes. Presented jointly at SynBio Markets 2019 on composites in aerospace industry.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2017-04-27
Description

Strategic partnership to develop high-performance products using Biosteel fiber. Collaboration since 2014 resulted in processing Biosteel on conventional knitting machines, revolutionizing textile production with biotechnologically produced synthetic silk fibers.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2016-11-17
Description

Partnership for Biosteel fiber in performance footwear. Launched world's first performance shoe (Futurecraft Biofabric) made from 100% biodegradable Biosteel fiber. Ongoing collaboration for larger-scale production of performance products.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2008-01-01
Description

University spin-off founded in 2008 from TUM. TUM remains a shareholder and scientific partner providing ongoing research collaboration and innovation support. TUM is one of Europe's top universities and a University of Excellence.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Japanese biotech company producing Brewed Protein™ fibers via fermentation, the closest direct competitor to AMSilk in bio-fabricated protein textiles and apparel partnerships with Goldwin and The North Face.

TypeEmerging player
Description

US-based startup producing bio-fabricated protein fibers from recycled and waste feedstocks; an emerging player targeting sustainable apparel and competing with AMSilk's fermentation-derived silk proteins.

TypeBroad incumbent
Description

Austrian specialty fiber producer of wood-based cellulosic fibers (TENCEL™ Lyocell, Modal, Viscose); a broad incumbent in sustainable/bio-based textile fibers competing for the same brand-customer sustainability budgets.

TypeDirect peer
Description

US-based bio-fabrication company producing b-silk protein fibers and Mylo™ mycelium leather; competes directly with AMSilk in the bioengineered silk and luxury/footwear apparel space.

TypeBroad incumbent
Description

German specialty chemicals company and AMSilk's contract manufacturing partner for silk protein fermentation; broader portfolio of bio-based and specialty ingredients competes for the same bioeconomy customers.

TypeEmerging player
Description

US biotech firm developing bio-fabricated proteins and sustainable materials for fashion and automotive applications, overlapping with AMSilk's protein engineering and brand-partnership model.

TypeEmerging player
Description

Finnish company producing sustainable textile fibers from wood pulp and waste streams without chemical solvents; an emerging bio-based alternative to AMSilk's fermentation-derived silk proteins.

TypeBroad incumbent
Description

Global chemicals giant with biotechnology and bio-based materials operations; a broad incumbent whose scale, R&D, and fermentation capabilities position it as a potential competitor or acquirer in bio-fabricated materials.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AMSilk

Biofabricated Silk Protein Materialsamsilk.com

AMSilk GmbH produces biofabricated silk proteins via precision fermentation, supplying fibers, yarns, hydrogels, and powders to enterprise customers in luxury fashion, automotive, aerospace, medical, and consumer care industries through direct B2B sales and contract manufacturing partners Evonik and Ajinomoto.

What AMSilk does

AMSilk GmbH is a German industrial biotechnology company founded in 2008 as a spin-off from the Technical University of Munich that produces biofabricated silk proteins through precision fermentation using genetically engineered microorganisms. The company's core platform combines DNA editing with AI-powered protein design to engineer spider-silk-inspired proteins, which are then processed into a portfolio of physical forms including fibers and yarns (Biosteel®), hydrogels (Silkgel), microparticles (Silkbeads), sprayable formulations, and powders (AMSilk4Care, AMSilk4Shine). Products are positioned as biodegradable, vegan-certified, microplastic-free alternatives to conventional silk and synthetic polymers, with claimed performance characteristics including up to 120 kg CO2-equivalent savings per kilogram of fiber and 99.7% reduction in microbial adherence in medical coating applications.

AMSilk serves enterprise customers across five primary business units: textile and fashion (Balenciaga Spring 2026 collection, adidas Futurecraft Biofabric), medical technology (coatings, wound dressings, surgical mesh), consumer care (laundry, dish, surface, and personal care formulators), automotive (Mercedes-Benz VISION EQXX door pulls), and aviation (Airbus composite fibers). The company does not own fermentation plants; instead, it operates an asset-light contract manufacturing model through dedicated lines at Evonik in Slovakia and Ajinomoto Foods Europe in France, with multi-ton monthly output and a publicly stated target of scaling capacity by several thousand tons per year within 3-5 years.

Revenue is generated through a mix of B2B biomaterial sales (fibers, yarns, powders, hydrogels, coatings), licensing and strategic partnership agreements under a three-tier model (Partnership, Preferred Partnership, Strategic Partnership), and consumer care ingredient supply. Cumulative disclosed funding exceeds EUR 106M across a EUR 54M Series C (2021-2023) and a EUR 52M round in September 2025 led by ATHOS (AT Newtec, majority shareholder), with participation from Novo Holdings, Cargill, and MIG Capital. As of June 2026, leadership transitioned to a new CEO (Christian Wichert, ex-Evolva AG) explicitly tasked with moving the company from development and scale-up to full commercialization.

AMSilk firmographics

Firmographics
Name
AMSilk
Legal name
AMSilk GmbH
Website
https://amsilk.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
51–100 employees
Short description
AMSilk GmbH produces biofabricated silk proteins via precision fermentation, supplying fibers, yarns, hydrogels, and powders to enterprise customers in luxury fashion, automotive, aerospace, medical, and consumer care industries through direct B2B sales and contract manufacturing partners Evonik and Ajinomoto.
Ownership category
akta.pro rank

AMSilk industry classification

Industry
Product category
Biofabricated Silk Protein Materials
NAICS
Artificial and Synthetic Fibers and Filaments Manufacturing (32522), Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing (3252)
SIC
Broadwoven Fabric Mills, Man Made Fiber & Silk (2221)
akta.pro industry
PRIMARYIMAOAAAB
Man-Made Fiber Manufacturing (Polyester/Nylon/Acrylic/Viscose)
SECONDARYIMAOABAH
Technical Fabric Mills (Performance/Protective/Medical Substrates)
SECONDARYIMAOADAD
Medical & Hygiene Technical Textiles (Gauze/Drapes/Wipes/Barrier Fabrics)
SECONDARYIMAMALAK
Bio-based Textiles & Fibers (lyocell/viscose, cellulose filament, nonwovens)

Keywords

  • Biotech silk proteins
  • Biofabricated materials
  • Precision fermentation proteins
  • Sustainable textile fibers
  • Biogenic material solutions

Where AMSilk is headquartered

Location

Headquarters

HQ city
Neuried
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

AMSilk business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain

Revenue model

  1. Biomaterial Sales: AMSilk generates revenue through the sale of biofabricated silk protein materials including fibers, yarns, powders, hydrogels, and coatings to industrial customers in textiles, medical, consumer care, automotive, and aviation sectors.
  2. Licensing and Partnership Agreements: Revenue generated from preferred and strategic partnership agreements with industry leaders, including technology licensing and custom product development collaborations.
  3. Consumer Care Ingredients: Sale of silk protein ingredients (AMSilk4Care, AMSilk4Shine) to consumer care product manufacturers for use in laundry care, dish care, personal care, and surface cleaning products.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

AMSilk product offering

Product offering

Core offering

AMSilk manufactures and sells biofabricated silk protein materials produced through precision fermentation using genetically engineered microorganisms. Its product portfolio includes high-performance silk protein yarns (Biosteel) for textiles, AMSilk4Care and AMSilk4Shine protein ingredients for consumer care products, and medical-grade coatings for implants, with applications spanning luxury fashion, athletic apparel, automotive interiors, aerospace, and medical devices.

Differentiator

Problem solved

Functional benefit

Brands

  • Biosteel®: High-performance bio-fabricated silk protein fiber brand for textiles and industrial applications
  • AMSilk4Care
  • AMSilk4Shine

Products and services

  • AMSilk Silk Protein Yarns (Biosteel) High-performance biofabricated silk protein yarns (Biosteel) produced via precision fermentation and proprietary wet spinning for textile applications including luxury fashion garments, performance footwear, technical textiles, automotive interiors, and aerospace composites. Customers include adidas, Balenciaga, Mercedes-Benz, Airbus, and OMEGA.
  • AMSilk4Care Pure biotech silk protein formulation for consumer care applications including laundry care, surface cleaning, hair care, and skin care products. Sold as a functional, biodegradable ingredient to consumer care product manufacturers seeking alternatives to synthetic polymers.
  • AMSilk4Shine Silk shine protein ingredient designed for dish care formulations, delivering surface protection, anti-spotting, and anti-streaking performance in home care products. Sold to consumer care manufacturers as a biodegradable alternative to synthetic polymers.

Quantifiable outcome

  • Up to 120 kg CO2 equivalent saved per kilogram of AMSilk fiber replacing conventional silk
  • +2 more outcomes

Companies that use AMSilk

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles5 records

AMSilk technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

AMSilk partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered flagship, core and major.

  • BalenciagaflagshipStrategic or Co-development Partner · 21 January 2026Bioengineered silk protein yarns featured in commercially available garments within Balenciaga's Spring 2026 collection. Significant milestone demonstrating biotech materials meet luxury fashion requirements.
  • Ajinomoto Foods EuropecoreTechnology or Integration · 16 October 2024Strategic partnership for industrial fermentation of silk proteins at Ajinomoto's facility in Nesle, France. Leverages Ajinomoto's 50+ years of fermentation expertise, bioreactors exceeding 100m³ scale, and proximity to European customers with renewable energy and local raw materials.
  • BRAIN BiotechmajorStrategic or Co-development Partner · 5 March 2024Strategic R&D collaboration for protein engineering. Using rational design and AI-powered technologies to optimize structural proteins at amino acid level for performance materials. Successfully registered first PCT patent for optimized protein.
  • 21st.BIOmajorTechnology or Integration · 17 January 2024Partnership to accelerate production of advanced materials made from spider silk-based proteins. New protein production strain delivers unprecedented yield with greater efficiency and lower costs.
  • EvonikcoreTechnology or Integration · 4 April 2023Long-term manufacturing partnership with dedicated production line at Evonik's Slovakian site for industrial-scale silk protein production. Evonik provides precision fermentation capabilities with advanced infrastructure and renewable energy, producing several tons of silk proteins monthly.
  • Mercedes-BenzflagshipStrategic or Co-development Partner · 3 January 2022Partnership to develop sustainable bio-based door pulls for VISION EQXX concept car. First use of biotechnology-based certified-vegan silk-like fabric in automotive sector, showcasing application potential of AMSilk's technology.
  • AirbusflagshipStrategic or Co-development Partner · 12 September 2018Partnership to develop next generation composite fibers for lightweight, high-performance planes. Presented jointly at SynBio Markets 2019 on composites in aerospace industry.
  • Gruschwitz Textilwerke AGmajorStrategic or Co-development Partner · 27 April 2017Strategic partnership to develop high-performance products using Biosteel fiber. Collaboration since 2014 resulted in processing Biosteel on conventional knitting machines, revolutionizing textile production with biotechnologically produced synthetic silk fibers.
  • adidasflagshipStrategic or Co-development Partner · 17 November 2016Partnership for Biosteel fiber in performance footwear. Launched world's first performance shoe (Futurecraft Biofabric) made from 100% biodegradable Biosteel fiber. Ongoing collaboration for larger-scale production of performance products.
  • Technical University of Munich (TUM)majorStrategic or Co-development Partner · 1 January 2008University spin-off founded in 2008 from TUM. TUM remains a shareholder and scientific partner providing ongoing research collaboration and innovation support. TUM is one of Europe's top universities and a University of Excellence.

Scale indicators7 records

Recent moves8 records

Expansion highlights7 records

AMSilk competitors and assessment

Company assessment

Direct peers

  • Spiber: Japanese biotech company producing Brewed Protein™ fibers via fermentation, the closest direct competitor to AMSilk in bio-fabricated protein textiles and apparel partnerships with Goldwin and The North Face.
  • Bolt Threads: US-based bio-fabrication company producing b-silk protein fibers and Mylo™ mycelium leather; competes directly with AMSilk in the bioengineered silk and luxury/footwear apparel space.

Emerging players

  • Protein Evolution: US-based startup producing bio-fabricated protein fibers from recycled and waste feedstocks; an emerging player targeting sustainable apparel and competing with AMSilk's fermentation-derived silk proteins.
  • Modern Meadow: US biotech firm developing bio-fabricated proteins and sustainable materials for fashion and automotive applications, overlapping with AMSilk's protein engineering and brand-partnership model.
  • Spinnova: Finnish company producing sustainable textile fibers from wood pulp and waste streams without chemical solvents; an emerging bio-based alternative to AMSilk's fermentation-derived silk proteins.

Broad incumbents

  • Lenzing AG: Austrian specialty fiber producer of wood-based cellulosic fibers (TENCEL™ Lyocell, Modal, Viscose); a broad incumbent in sustainable/bio-based textile fibers competing for the same brand-customer sustainability budgets.
  • Evonik Industries: German specialty chemicals company and AMSilk's contract manufacturing partner for silk protein fermentation; broader portfolio of bio-based and specialty ingredients competes for the same bioeconomy customers.
  • BASF: Global chemicals giant with biotechnology and bio-based materials operations; a broad incumbent whose scale, R&D, and fermentation capabilities position it as a potential competitor or acquirer in bio-fabricated materials.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

AMSilk social profiles

Digital presence

AMSilk financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AMSilk leadership team

Management profile

Number of profiles

Profiles8 records

AMSilk funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AMSilk M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AMSilk

What does AMSilk do?

AMSilk manufactures and sells biofabricated silk protein materials produced through precision fermentation using genetically engineered microorganisms. Its product portfolio includes high-performance silk protein yarns (Biosteel) for textiles, AMSilk4Care and AMSilk4Shine protein ingredients for consumer care products, and medical-grade coatings for implants, with applications spanning luxury fashion, athletic apparel, automotive interiors, aerospace, and medical devices.

Is AMSilk a public or private company?

AMSilk is a private company. It is classified as venture growth investor backed and is currently operating.

When was AMSilk founded?

AMSilk was founded in 2008. It employs 51 to 100 people.

Where is AMSilk based?

AMSilk is headquartered in Neuried, Germany, in the Europe region.

How does AMSilk make money?

Three revenue lines are on record. Biomaterial Sales are the primary driver. The others are licensing and Partnership Agreements and consumer Care Ingredients.

Who are AMSilk's main competitors?

Direct peers on record are Spiber and Bolt Threads. Emerging players are Protein Evolution, Modern Meadow and Spinnova. Broad incumbents are Lenzing AG, Evonik Industries and BASF.

Does AMSilk have an API?

No public API is recorded for AMSilk.

What industry is AMSilk in?

AMSilk's product category is Biofabricated Silk Protein Materials. Its primary akta.pro industry code is IMAOAAAB, Man-Made Fiber Manufacturing (Polyester/Nylon/Acrylic/Viscose), with a secondary code of IMAOABAH, Technical Fabric Mills (Performance/Protective/Medical Substrates). Its NAICS code is 32522 and its SIC code is 2221.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
WWDSilky Smooth: How Luxury Is Shaping Fiber Choices in DenimDenim mills and brands are increasingly blending silk, cashmere and spider silk into cotton denim to add softness, sheen, moisture management and sustainability credentials. Silk accounts for well below 5 percent of Pioneer Denim's volume, while AMSilk plans to scale spider silk production from 30 tons this year to 700 tons by 2030. Mills say adoption remains selective due to cost, with 8–10 percent blends typical.vegconomistAMSilk Silk Protein Yarns Appear in Balenciaga Couture Gown at Paris ShowBalenciaga featured an evening cocoon gown made with AMSilk's bioengineered silk protein material at its 55th Couture Collection presentation during Paris Haute Couture Week, marking Creative Director Pierpaolo Piccioli's first couture show for the house. This couture appearance follows the debut of AMSilk's yarns in commercially available Balenciaga garments from the Spring 2026 ready-to-wear collection, expanding an existing fashion partnership. AMSilk produces its silk proteins through precision fermentation using spider silk-based structures, with the resulting yarns described as fully protein-based, biodegradable, and free of microplastics.The Manila TimesAMSilk collaboration: Biotech silk protein yarns feature in Balenciaga 55th Couture CollectionAMSilk announced that its bioengineered silk protein yarns were featured in Balenciaga’s 55th Couture Collection, specifically in an evening gown designed by Creative Director Pierpaolo Piccioli. This collaboration highlights the versatility of AMSilk's sustainable, biodegradable biomaterials and serves as a validation of their technology within the luxury fashion sector.GlobeNewswireAMSilk collaboration: Biotech silk protein yarns feature in Balenciaga 55th Couture CollectionAMSilk announced its bioengineered silk protein yarns were featured in Balenciaga's 55th Couture Collection, including an evening cocoon gown made from AMSilk-blend fabric. The collaboration highlights the company's sustainable, protein-based materials for luxury fashion.GlobeNewswireAMSilk collaboration: Biotech silk protein yarns feature in Balenciaga 55th Couture CollectionAMSilk, a German biotech company specializing in bioengineered silk protein yarns, announces that its materials have been featured in Balenciaga's 55th Couture Collection, appearing in an evening cocoon gown designed by Creative Director Pierpaolo Piccioli. The collaboration represents the latest development in AMSilk's partnership with the French luxury fashion house and is described by AMSilk's COO as "a meaningful milestone" and "important validation of our technology." The article positions this as evidence of the luxury fashion industry's growing interest in scalable, sustainable alternatives to conventional fabrics while highlighting the increasing commercial viability of biotechnology-enabled materials in high-end fashion.GlobeNewswireAMSilk and Ajinomoto Foods Europe Expand Partnership to Enable Industrial-Scale Production of Silk ProteinsAMSilk, a German biotech company specializing in silk proteins, announced a significant expansion of its partnership with Ajinomoto Foods Europe (AFE) through a long-term manufacturing and supply agreement to scale industrial production. AFE will establish a dedicated production line at its biomanufacturing site in Nesle, France, featuring 160 m³ fermentation reactor capacity with customized downstream processing capabilities, supported by a multi-million joint investment in equipment and facility upgrades. The agreement is designed to enable AMSilk to reach commercial production volumes targeting hundreds of tons per year, serving markets including textiles, automotive, and consumer care, while providing AFE with expanded contract manufacturing capabilities.YahooChristian Wichert named new CEO of AMSilkChristian Wichert has been appointed as the new CEO of AMSilk, a biomaterials company specializing in silk protein-based products. Wichert brings over 25 years of leadership experience, most recently serving as CEO of Swiss biotechnology company Evolva, which was sold to Danstar Ferment AG/Lallemand Group during his tenure. In his new role, Wichert will focus on scaling commercial operations and expanding AMSilk's silk protein technology into broader applications and markets.Just StyleChristian Wichert named new CEO of biomaterials firm AMSilkChristian Wichert was named CEO of AMSilk, effective 1 June, to lead commercial operations and expand its silk protein technology. He brings over 25 years of experience, including as CEO of Evolva, and will focus on Consumer Care Solutions. Ulrich Scherbel will remain as managing director and COO.GlobeNewswireChristian Wichert appointed Chief Executive Officer to lead next phase of growthAMSilk GmbH announced the appointment of Christian Wichert as its new Chief Executive Officer, effective June 1st, as the company transitions from development and scale-up phases toward full commercialization. Wichert brings over 25 years of international leadership experience, most recently serving as CEO of Swiss biotechnology company Evolva AG, and will focus on strengthening commercial performance and scaling the company's proprietary silk protein technology and precision fermentation capabilities. The appointment builds on AMSilk's successful market entry through its biotech silk protein yarns, notably featured in Balenciaga's Spring 2026 collection, and its strategic partnerships with 21st.BIO, Evonik, and Ajinomoto.